Apr 30, 2026 07:30AM
Apr 29, 2026 10:00AM
Apr 29, 2026 05:52AM
Apr 29, 2026 05:30AM
Apr 15, 2026 07:30AM
Apr 15, 2026 07:30AM
Mar 27, 2026 08:01AM Organon presents new VTAMA cream data showing early atopic dermatitis improvement
Mar 27, 2026 08:00AM
Feb 27, 2026 08:00AM
Feb 27, 2026 08:00AM
Feb 23, 2026 07:30AM
Feb 23, 2026 07:30AM
Feb 16, 2026 05:31PM
Feb 12, 2026 07:30AM Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025
Jan 16, 2026 09:12PM
Nov 17, 2025 04:04PM
Nov 17, 2025 05:30AM
Nov 17, 2025 05:30AM
Nov 10, 2025 07:30AM
Nov 8, 2025 08:00AM
Sep 19, 2025 06:00AM European Commission approves Henlius and Organon denosumab biosimilars
Sep 19, 2025 06:00AM
Sep 2, 2025 05:31AM
Sep 2, 2025 05:30AM
Aug 5, 2025 07:30AM
Jul 7, 2025 07:31AM
Jul 7, 2025 07:30AM
May 27, 2025 07:34AM Organon (OGN) and Samsung Bioepis Granted FDA Interchangeability Designation
May 27, 2025 07:30AM
May 1, 2025 07:00AM
Apr 1, 2025 07:31AM
Apr 1, 2025 07:30AM
Mar 28, 2025 06:00AM
Mar 10, 2025 12:01AM
Mar 8, 2025 09:00AM New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Old
Feb 13, 2025 07:30AM
Dec 16, 2024 07:30AM
Dec 16, 2024 07:30AM
Nov 5, 2024 07:29AM
Nov 5, 2024 07:29AM
Oct 30, 2024 06:05AM
Oct 30, 2024 06:00AM US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
Oct 28, 2024 09:25AM
Oct 28, 2024 09:25AM
Sep 23, 2024 04:27PM
Sep 18, 2024 07:30AM
Sep 18, 2024 07:30AM
Feb 20, 2024 08:03AM
Feb 20, 2024 08:00AM Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary
Nov 7, 2023 04:16PM

322,096 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All